Abdennour Braka
Research Subjects
Abdennour Braka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Sangwook Wu
Department of Physics, Pukyong National University, Busan 48513, Republic of Korea
2 shared publications - Goutam Mukherjee
R&D Center, PharmCADD Co. Ltd., 12F, 331, Jungang-daero, Dong-gu, Busan 48792, Republic of Korea
1 shared publication - Hyun Jung Yoon
PharmCADD
1 shared publication - Indrajit Deb
University of Calcutta
1 shared publication - Muhammad Jan Akhunzada
PharmCADD
1 shared publication - Pascal Bonnet
Institut de Chimie Organique et Analytique; UMR7311; CNRS, University of Orléans, 45071 ORLEANS Cedex2, France
1 shared publication
Latest Publications
- Open Access
- 7 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Using Dynamic Interaction Fingerprints to Derive Baseline Machine Learning Model for the Prediction of Protein-Ligand Dissociation Rate Constant
Model building for the prediction of protein-ligand unbinding kinetics gaining popularity with the increasing availability of experimental structural data for the protein-ligand complexes and their relevant kinetic parameters. Limited but major effort has been already put forward in choosing appropriate machine learning (ML) methods among the popular ones like least squares (LS), support vector machine (SVM), random forest (RF), and a few more. The RF and Bayesian neural network (BNN) algorithms have been reported to be promising when combined with advanced descriptors representing ligand properties and protein-ligand interactions. However, the selection of descriptors that would correlate well with the unbinding kinetic properties is still a challenge. In this work, we derived a baseline RF model using descriptors representing the protein-ligand interaction fingerprints (IFPs) along the ligand unbinding pathway otherwise can be called dynamic IFPs. We found that the dynamic IFPs in addition to the static or binding pocket IFPs significantly improved the quality of our model for the prediction of ligand dissociation rate constant (koff). To the best of our knowledge, this work is the first attempt towards using the dynamic IFPs in deriving a quantitative structure-kinetics relationship (QSKR) model for the prediction of koff.
- 7 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessUsing Dynamic Interaction Fingerprints to Derive Baseline Machine Learning Model for the Prediction of Protein-Ligand Dissociation Rate Constant
Model building for the prediction of protein-ligand unbinding kinetics gaining popularity with the increasing availability of experimental structural data for the protein-ligand complexes and their relevant kinetic parameters. Limited but major effort has been already put forward in choosing appropriate machine learning (ML) methods among the popular ones like least squares (LS), support vector machine (SVM), random forest (RF), and a few more. The RF and Bayesian neural network (BNN) algorithms have been reported to be promising when combined with advanced descriptors representing ligand properties and protein-ligand interactions. However, the selection of descriptors that would correlate well with the unbinding kinetic properties is still a challenge. In this work, we derived a baseline RF model using descriptors representing the protein-ligand interaction fingerprints (IFPs) along the ligand unbinding pathway otherwise can be called dynamic IFPs. We found that the dynamic IFPs in addition to the static or binding pocket IFPs significantly improved the quality of our model for the prediction of ligand dissociation rate constant (koff). To the best of our knowledge, this work is the first attempt towards using the dynamic IFPs in deriving a quantitative structure-kinetics relationship (QSKR) model for the prediction of koff.
- 7 March 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (7) , 2073-2083
Quantifying Functional-Group-like Structural Fragments in Molecules and Its Applications in Drug Design
A functional group in a molecule is a structural fragment consisting of a few atoms or a single atom that imparts reactivity to a molecule. Hence, defining functional groups is crucial in chemistry to predict the properties and reactivities of molecules. However, there is no established method in the literature for defining functional groups based on reactivity parameters. In this work, we addressed this issue by designing a set of predefined structural fragments along with reactivity parameters like electron conjugation and ring strain. This approach uses bond orders and atom connectivities to quantify the presence of these fragments within an organic molecule based on a given input molecular coordinate. To assess the effectiveness of this approach, we performed a case study to show the benefits of using these newly designed structural fragments instead of traditional fingerprint-based methods for grouping potential COX1/COX2 inhibitors by screening an approved drug library against aspirin molecule. The structural fragment-based model for ternary classification of rat oral LD50 of chemicals showed performance similar to the fingerprint-based models. In evaluating the regression model performance for aqueous solubility, log(S), predictions, our approach outperformed the fingerprint-based model.
- 7 March 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (7) , 2073-2083
Quantifying Functional-Group-like Structural Fragments in Molecules and Its Applications in Drug Design
A functional group in a molecule is a structural fragment consisting of a few atoms or a single atom that imparts reactivity to a molecule. Hence, defining functional groups is crucial in chemistry to predict the properties and reactivities of molecules. However, there is no established method in the literature for defining functional groups based on reactivity parameters. In this work, we addressed this issue by designing a set of predefined structural fragments along with reactivity parameters like electron conjugation and ring strain. This approach uses bond orders and atom connectivities to quantify the presence of these fragments within an organic molecule based on a given input molecular coordinate. To assess the effectiveness of this approach, we performed a case study to show the benefits of using these newly designed structural fragments instead of traditional fingerprint-based methods for grouping potential COX1/COX2 inhibitors by screening an approved drug library against aspirin molecule. The structural fragment-based model for ternary classification of rat oral LD50 of chemicals showed performance similar to the fingerprint-based models. In evaluating the regression model performance for aqueous solubility, log(S), predictions, our approach outperformed the fingerprint-based model.
- 7 April 2016
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 8 (5) , 545-566
Advanced Molecular Dynamics Simulation Methods for Kinase Drug Discovery
Interest in the application of molecular dynamics (MD) simulations has increased in the field of protein kinase (PK) drug discovery. PKs belong to an important drug target class because they are directly involved in a number of diseases, including cancer. MD methods simulate dynamic biological and chemical events at an atomic level. This information can be combined with other in silico and experimental methods to efficiently target selected receptors. In this review, we present common and advanced methods of MD simulations and we focus on the recent applications of MD-based methodologies that provided significant insights into the elucidation of biological mechanisms involving PKs and into the discovery of novel kinase inhibitors.
- 7 April 2016
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 8 (5) , 545-566
Advanced Molecular Dynamics Simulation Methods for Kinase Drug Discovery
Interest in the application of molecular dynamics (MD) simulations has increased in the field of protein kinase (PK) drug discovery. PKs belong to an important drug target class because they are directly involved in a number of diseases, including cancer. MD methods simulate dynamic biological and chemical events at an atomic level. This information can be combined with other in silico and experimental methods to efficiently target selected receptors. In this review, we present common and advanced methods of MD simulations and we focus on the recent applications of MD-based methodologies that provided significant insights into the elucidation of biological mechanisms involving PKs and into the discovery of novel kinase inhibitors.